RHO and breast cancer: Here, we demonstrate that SEPT9_i1 promotes breast cancer cell migration, cytoskeletal rearrangements and FA turnover by targeting Rho/ROCK and FAK signaling in vitro and increases the metastatic potential of breast cancer in vivo.